Treatment of Complex Regional Pain Syndrome
Launched by MCMASTER UNIVERSITY · Jan 14, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to help people with Complex Regional Pain Syndrome (CRPS), a condition that causes severe pain, often in a hand. The researchers are testing a technique called repetitive transcranial magnetic stimulation (rTMS), which uses magnetic pulses to stimulate the brain, along with a training task that helps with movement. The goal is to see if this combination can effectively reduce pain and if it's practical for patients to participate in the study.
To join the trial, participants need to be diagnosed with CRPS type 1 affecting one of their hands. However, those with severe pain in other body parts, regular use of strong pain medications like opioids before their CRPS diagnosis, or certain health issues that could affect the treatment cannot participate. If eligible, participants can expect to engage in the rTMS sessions and the sensorimotor training, while the researchers monitor how well these methods work for managing their pain. This study is currently recruiting individuals between the ages of 18 and 80 who are willing to try this innovative approach.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A diagnosis of CRPS type 1 affecting one of their hands
- Exclusion Criteria:
- • A known history of moderate to severe chronic pain in other parts of the body
- • Daily use of opioids prior to the CRPS diagnosis
- • Contraindications to transcranial magnetic stimulation
- • Known psychological diagnosis affecting comprehension
- • Inability to participate in the study
About Mcmaster University
McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamilton, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials